The evolution of the biotechnology industry in Germany.

Full Abstract

In the past five years, the climate for commercial biotechnology in Germany has improved significantly and has resulted in an increase in the number of biotechnology companies. On examination of the underlying factors of the evolution of the biotechnology industry in Germany, and against the background of the current situation, it is predicted that many German biotech companies will have to change their business models to focus on product development rather than on platform technologies.

Author information

Author/s: Müller, Christian (C);

Affiliation: Technical University of Hamburg-Harburg, Institute for Technology and Innovation Management, Hamburg, Germany. mueller(-atsign-)bioinnotec.de

Journal and publication information

Publication Type: Journal Article

Journal: Trends in biotechnology (Trends Biotechnol), published in England. (Language: eng)

Reference: 2002-Jul; vol 20 (issue 7) : pp 287-90

Dates: Created 2002/06/13; Completed 2002/11/20;

PMID: 12062972, status: MEDLINE (last retrieved date: 2/18/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.